Rite Aid Corporation (NYSE: RAD) today announced sales results for September.
Monthly SalesFor the four weeks ended Sept. 29, 2012, same store sales decreased 0.7 percent over the prior-year period. September front-end same store sales increased 2.8 percent. Pharmacy same store sales, which included an approximate 911 basis points negative impact from new generic introductions, decreased 2.3 percent. Prescription count at comparable stores increased 4.4 percent over the prior-year period.
Total drugstore sales for the four-week period decreased 1.5 percent to $1.899 billion compared to $1.927 billion for the same period last year. Prescription sales accounted for 67.8 percent of drugstore sales, and third party prescription sales represented 96.5 percent of pharmacy sales.
Year-to-Date SalesSame store sales for the 30-week period ended Sept. 29, 2012 increased 0.9 percent over the prior-year period. Front-end same store sales increased 2.1 percent while pharmacy same store sales increased 0.4 percent. Prescription count at comparable stores increased 3.6 percent over the prior-year period.Total drugstore sales for the 30 weeks ended Sept. 29, 2012 increased 0.2 percent with sales of $14.545 billion compared to $14.513 billion for the same period last year. Prescription sales represented 67.9 percent of total drugstore sales, and third party prescription sales represented 96.6 percent of pharmacy sales. Rite Aid is one of the nation’s largest drugstore chains. On Sept. 29, 2012, the company operated 4,639 stores compared to 4,694 stores in the like period a year ago. Information about Rite Aid, including corporate background and press releases, is available through the company’s website at http://www.riteaid.com. Note that all sales data in this release is preliminary, unaudited and subject to revision. Statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties that are described in Item 1A (Risk Factors) of our most recent Annual Report on Form 10-K and in other documents that we file or furnish with the Securities and Exchange Commission, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Rite Aid expressly disclaims any current intention to update publicly any forward-looking statement after the distribution of this release, whether as a result of new information, future events, changes in assumptions or otherwise.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV